Targeting the membrane-anchored serine protease testisin with a novel engineered anthrax toxin prodrug to kill tumor cells and reduce tumor burden

Erik W. Martin(National Institute on Aging), Toni Antalis(U-M Rogel Cancer Center)
Oncotarget
September 15, 2015
Cited by 16


Related Papers